# Repligen Corporation (RGEN): MoatMap facts

As of 11 Nov 2026. Research data, not investment advice.

As of 11 Nov 2026, the MoatMap Score for Repligen Corporation (RGEN) is 53/100, ranked against 25,000+ stocks in 38 markets (Quality 52, Value 18, Momentum 78, each scored against its sector).

- MoatMap Score: 53/100, a percentile across 25,000+ stocks in 38 markets (100 is best).
- Quality 52, Value 18, Momentum 78: each a 0-100 percentile within Healthcare.
- Position: #12,601 overall, #1,167 in Healthcare.
- Listing: United States, NMS; Healthcare / Medical Instruments & Supplies.
- Last close: 172.62 USD on 11 Nov 2026.
- Insider filings, last 180 days: directors sold USD 6.1M.

Source: https://moatmap.ai/stock/RGEN
How the scores work: https://moatmap.ai/methodology
Does the score work? Each tenth of the ranking is tracked monthly: https://moatmap.ai/decile-tracker